Price
No data yet.
Social Signal Score
Company Profile
- CEO
- Richard L. Van Kirk
- Sector
- Financial Services
- Industry
- Asset Management
- Employees
- 142
- Beta
- 0.80
- Country
- US
Quote
Valuation & Ratios
Returns & Efficiency
Valuation
PEXhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
98+2.63%Social Signal Score
Mentions (2)
- Newsnewsfilecorp.com·6h ago·Neutral
Rhelion Life Sciences Confirms Further Delivery of Filament Health's PEX010 to Germany's First Psilocybin Compassionate Use Program Filament Health has completed a further international delivery of its patented, naturally derived psilocybin drug candidate PEX010 to Germany, supporting the first compassionate use program for psilocybin in the European Union The Company believes the continued delivery demonstrates Filament's ability to manufacture, release and supply pharmaceutical-grade botanical…
View source ↗ - Newsnewsfilecorp.com·9d ago·Neutral
Rhelion Life Sciences Wholly Owned Subsidiary Filament Health Completes Shipment of PEX010 for University of Washington Phase 2a Trial in Cancer-Related Anxiety and Depression Filament Health's patented, naturally derived psilocybin drug candidate PEX010 will be supplied to an investigator initiated Phase 2a study evaluating a group retreat model of psilocybin therapy in people living with metastatic solid tumors or incurable hematologic malignancies. Toronto, Ontario--(Newsfile Corp. - August 2…
View source ↗
Insider trading
Open-market buys and sells by PEX officers and directors.
- Bought
- $736k
- Sold
- $3.7m
1 trade
4 trades
- Deutsche Bank Ag\sold
- Deutsche Bank Ag\sold
- Deutsche Bank Ag\sold
- Deutsche Bank Ag\sold
- Deutsche Bank Ag\bought
14 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.